We have observed
2 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 24, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Aqueous pharmaceutical compositions containing borate-polyol complexes
mTOR/JAK INHIBITOR COMBINATION THERAPY